Literature DB >> 11714650

Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.

M Melter1, A Exeni, M E Reinders, J C Fang, G McMahon, P Ganz, W W Hancock, D M Briscoe.   

Abstract

BACKGROUND: Chemokines play an essential role in regulating the infiltration of leukocytes into allografts in experimental models. Little is known of their expression or function after human cardiac transplantation. METHODS AND
RESULTS: We analyzed 169 sequential human endomyocardial biopsies by immunocytochemistry for infiltration by CD3(+) T cells and the expression of the chemokine receptors CCR1, CCR3, CCR5, and CXCR3. In both cross-sectional and longitudinal analyses, the expression of each of the chemokine receptors correlated with the degree of CD3(+) T-cell infiltration. In particular, the expression of CXCR3 was temporally and spatially associated with CD3(+) T-cell infiltrates and correlated with the histopathological diagnosis of acute rejection (OR, 11.73 and 4.05, respectively; P<0.001). Of 7 patients followed up longitudinally for 1 year, 4 with consecutive biopsies developed intimal thickening by intravascular ultrasound. In these patients, there was a trend for persistent expression of CD3- and CXCR3-expressing infiltrates in the later part of the first posttransplant year. The chemokines eotaxin, IP-10, lymphotactin, MCP-1, Mig, RANTES, and SDF-1 were examined in an additional 35 biopsies by RT-PCR. Eotaxin, lymphotactin, MCP-1, Mig, and SDF-1 were present in both normal and rejecting biopsies. However, the CXCR3 ligand IP-10, which was rarely expressed in normal biopsies, was markedly induced in acute rejection (OR, 19.43; P=0.01).
CONCLUSIONS: The presence of CXCR3(+) T cells and the CXCR3 ligand IP-10 within endomyocardial biopsies is strongly associated with acute rejection. The CXCR3-IP-10 interaction warrants consideration as a therapeutic target in the management of cardiac allograft recipients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714650     DOI: 10.1161/hc4601.098010

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

Review 1.  Stem cell origins of intimal cells in graft arterial disease.

Authors:  Koichi Shimizu; Richard N Mitchell
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

Review 2.  Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.

Authors:  Sarah Bruneau; Johannes Wedel; Fadi Fakhouri; Hironao Nakayama; Leo Boneschansker; Daniel Irimia; Kevin P Daly; David M Briscoe
Journal:  Pediatr Nephrol       Date:  2015-04-24       Impact factor: 3.714

3.  Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Authors:  D J Scholten; M Canals; M Wijtmans; S de Munnik; P Nguyen; D Verzijl; I J P de Esch; H F Vischer; M J Smit; R Leurs
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 4.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 5.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

6.  CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction.

Authors:  Njabulo Ngwenyama; Ane M Salvador; Francisco Velázquez; Tania Nevers; Alexander Levy; Mark Aronovitz; Andrew D Luster; Gordon S Huggins; Pilar Alcaide
Journal:  JCI Insight       Date:  2019-04-04

7.  Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.

Authors:  A Hoerning; S Köhler; C Jun; J Lu; J Fu; B Tebbe; S Dolff; T Feldkamp; A Kribben; P F Hoyer; O Witzke
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

8.  Development of a novel chemokine-mediated in vivo T cell recruitment assay.

Authors:  Gabriele S V Campanella; Benjamin D Medoff; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  J Immunol Methods       Date:  2008-01-09       Impact factor: 2.303

9.  CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells.

Authors:  Jonathan C Choy; Tai Yi; Deepak A Rao; George Tellides; Karen Fox-Talbot; William M Baldwin; Jordan S Pober
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

10.  Microfluidic mazes to characterize T-cell exploration patterns following activation in vitro.

Authors:  Namrata G Jain; Elisabeth A Wong; Alexander J Aranyosi; Leo Boneschansker; James F Markmann; David M Briscoe; Daniel Irimia
Journal:  Integr Biol (Camb)       Date:  2015-11       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.